https://www.selleckchem.com/pr....oducts/donafenib-sor
Most of the observed heterogeneity is ascribed to treatment duration for back pain (p = 0.045), influenza (p less then 0.001) and URTI (p less then 0.001), and significantly attributed to Body Mass Index (BMI) for nasopharyngitis (p less then 0.001).Conclusions Back pain, influenza, nasopharyngitis and URTI showed a significant heterogeneity of incidence estimates.The utility of a non-linear mixed effects model to model heart rate is examined. The heart rate acceleration is derived as a parameter from this model. The rela
Beğen
Yorum Yap
Paylaş
